文献速递慢性肾脏病

相位法自体荧光寿命成像FLIM可作为慢性肾实质损伤的定量生物标志物

Phasor approach to autofluorescence lifetime imaging FLIM can be a quantitative biomarker of chronic renal parenchymal injury.
PubMed 文献 · Kidney Int · 2020-05-28

本研究采用相位法荧光寿命成像(FLIM)分析糖尿病肾病患者冷冻活检组织的自体荧光寿命特征,发现相位寿命随疾病严重程度增加而整体升高,多组分相量分析可区分不同疾病状态,提示无染色的相位自体荧光寿命成像可用于评估肾脏疾病严重程度。

要点

  • 相位法FLIM无需染色即可定量评估肾组织自体荧光寿命改变。
  • 糖尿病肾病中相位寿命随疾病严重程度增加而整体升高。
  • 多组分相量分析可区分不同疾病状态。

核心结论

  • 相位自体荧光寿命成像可无染色地理解和评估肾脏疾病严重程度。

研究设计与样本

  • 对糖尿病肾病患者快冻活检材料的冷冻切片进行FLIM成像。

主要发现

  • 相位寿命(τphase)随疾病严重程度增加而整体升高。
  • 多组分相量分析显示不同疾病状态间存在显著差异。

临床怎么用

  • 相位自体荧光寿命成像有望作为评估慢性肾实质损伤严重程度的定量工具。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Diabetic kidney disease continues to be the leading cause of chronic kidney disease, often advancing to end stage kidney disease. In addition to the well characterized glomerular alterations including mesangial expansion, podocyte injury, and glomerulosclerosis, tubulointerstitial fibrosis is also an important component of diabetic kidney injury. Similarly, tubulointerstitial fibrosis is a critical component of any chronic kidney injury. Therefore, sensitive and quantitative identification of tubulointerstitial fibrosis is critical for the assessment of long-term prognosis of kidney disease. Here, we employed phasor approach to fluorescence lifetime imaging, commonly known as FLIM, to understand tissue heterogeneity and calculate changes in the tissue autofluorescence lifetime signatures due to diabetic kidney disease. FLIM imaging was performed on cryostat sections of snap-frozen biopsy material of patients with diabetic nephropathy. There was an overall increase in phase lifetime (τphase) with increased disease severity. Multicomponent phasor analysis shows the distinctive differences between the different disease states. Thus, phasor autofluorescence lifetime imaging, which does not involve any staining, can be used to understand and evaluate the severity of kidney disease.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Ranjit S, Henriksen K, Dvornikov A, et al. Phasor approach to autofluorescence lifetime imaging FLIM can be a quantitative biomarker of chronic renal parenchymal injury. Kidney Int. 2020. PMID: 32475606. doi:10.1016/j.kint.2020.02.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。